Home › Idiopathic Hypersomnia › Texas › Austin
Idiopathic Hypersomnia clinical trials in Austin, TX
6 studies for Idiopathic Hypersomnia are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Aayus Research, Austin
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
RecruitingPhase 2/3
- Takeda Site 20, Austin
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Austin
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3
- Future Search Trials - Austin Neurology, Austin
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Austin, Texas, Austin
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Austin, Texas, Austin
Idiopathic Hypersomnia trials in other cities
- Cincinnati, OH7 studies
- Charlotte, NC7 studies
- Orlando, FL6 studies
- Miami, FL6 studies
- Colorado Springs, CO5 studies
- Atlanta, GA5 studies
- Columbia, SC5 studies
- San Antonio, TX5 studies
- Sterling Heights, MI4 studies
- Columbus, OH4 studies
- Philadelphia, PA4 studies
- Brandon, FL4 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Prostate Cancer14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.